Johnson & Johnson: FDA approval of ICOTYDE (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...
NEXTpittsburgh

12+ things to do this weekend, from NatureFest to the Pittsburgh Fringe Festival

Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.
EuropaWire

Pearson and Tata Consultancy Services Partner to Deliver AI Driven Workforce Transformation and Enterprise Learning at Scale

Pearson and Tata Consultancy Services have formed a multi-year partnership to help enterprises develop future-ready workforces by combining AI-powered learning, assessment, and cloud-based ...